SM

Sayam Mittal

Active Director Director DIN 10455545
DIN 10455545 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sayam Mittal

Data last updated:

Sayam Mittal is a Director at Jamkas Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10455545
Primary Designation Director
Industry Pharma
First Appointment 08 Jan 2024
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jan 20242021Active

Directorship timeline

Open interactive timeline →
Jamkas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sayam Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sayam Mittal

Sayam Mittal currently holds 1 directorship: Jamkas Pharmaceuticals Private Limited (Director, since 08 Jan 2024).

Sayam Mittal was first appointed on 08 Jan 2024 as Director at Jamkas Pharmaceuticals Private Limited.

The current boards of Sayam Mittal's companies include Gurjinder Singh (Jamkas Pharmaceuticals Private Limited), Kanav Goyal (Jamkas Pharmaceuticals Private Limited), Manish Goyal (Jamkas Pharmaceuticals Private Limited), Rakesh Kumar (Jamkas Pharmaceuticals Private Limited), Rupali Singla (Jamkas Pharmaceuticals Private Limited), Vaneet Jain (Jamkas Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available